Aprea Therapeutics, Inc. (APRE)
NASDAQ: APRE · Real-Time Price · USD
0.7385
+0.0042 (0.57%)
At close: Jun 9, 2026, 4:00 PM EDT
0.7394
+0.0009 (0.12%)
Pre-market: Jun 10, 2026, 4:05 AM EDT
Aprea Therapeutics Market Cap
Aprea Therapeutics has a market cap or net worth of $8.85 million as of June 9, 2026. Its market cap has decreased by -3.62% in one year.
Market Cap
8.85M
Enterprise Value
-37.62M
1-Year Change
-3.62%
Ranking
Category
Stock Price
$0.74
Market Cap Chart
Since May 27, 2022, Aprea Therapeutics's market cap has decreased from $18.94M to $8.85M, a decrease of -53.27%. That is a compound annual growth rate of -17.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 8, 2026 | 8.80M | 47.49% |
| Dec 31, 2025 | 5.97M | -66.64% |
| Dec 31, 2024 | 17.88M | 1.81% |
| Dec 29, 2023 | 17.56M | 0.11% |
| Dec 30, 2022 | 17.54M | -7.36% |
| May 27, 2022 | 18.94M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kairos Pharma | 9.42M |
| Ernexa Therapeutics | 9.20M |
| Bolt Biotherapeutics | 8.76M |
| Curanex Pharmaceuticals | 8.59M |
| Addex Therapeutics | 8.56M |
| Bio Green Med Solution | 8.28M |
| Aptorum Group | 8.23M |
| Imunon | 8.21M |